---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-087248"
form_type: "8-K"
ticker: "ELOX"
cik: "0001035354"
company_name: "Eloxx Pharmaceuticals, Inc."
filed_at: "2023-08-03T23:59:59+00:00"
generated_at: "2026-06-12T06:58:43.284749+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Eloxx receives Nasdaq extension to Oct 9, 2023 to meet $35M market value rule

## Summary
- Nasdaq Hearings Panel extended compliance deadline for Listing Rule 5550(b)(2) from July 30 to October 9, 2023.
- Company must maintain at least $35 million market value of listed securities to avoid delisting.
- Extension follows a May 18, 2023 hearing and a July 27, 2023 request by Eloxx.
- Failure to regain compliance by October 9 could result in delisting from Nasdaq Capital Market.

## SEC filing metadata
- accession: 0001104659-23-087248
- form_type: 8-K
- ticker: ELOX
- cik: 0001035354
- company_name: Eloxx Pharmaceuticals, Inc.
- filed_at: 2023-08-03T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1035354/000110465923087248/0001104659-23-087248-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1035354/000110465923087248/tm2322789d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-087248
- JSON: https://secwatch.observer/filing/0001104659-23-087248.json
- Plain text: https://secwatch.observer/filing/0001104659-23-087248.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.